Montag & Caldwell’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$914K Buy
15,480
+6,379
+70% +$412K 0.2% 56
2025
Q1
$666K Hold
9,101
0.15% 61
2024
Q4
$753K Sell
9,101
-13
-0.1% -$1.02K 0.16% 60
2024
Q3
$652K Sell
9,114
-10,260
-53% -$724K 0.13% 62
2024
Q2
$1.33M Buy
19,374
+4,528
+30% +$271K 0.27% 39
2024
Q1
$796K Buy
+14,846
New +$798K 0.14% 54

Other funds holding GMED

Montag & Caldwell's GMED Position: Q2 2025 in Review

Montag & Caldwell increased its Globus Medical (GMED) stake by 70% in Q2 2025, buying an estimated $412K and bringing the position to 15,480 shares worth $914K. The position accounts for 0.2% of the portfolio, ranked #56.

Montag & Caldwell first reported a position in GMED in Q1 2024 and has held it in 6 quarters since. The position peaked at $1.33M in Q2 2024. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

  • Montag & Caldwell held 15,480 shares of Globus Medical worth $914K as of Q2 2025.
  • Montag & Caldwell bought 6,379 Globus Medical shares in Q2 2025, an estimated $412K.
  • Globus Medical made up 0.2% of Montag & Caldwell's portfolio in Q2 2025, its #56 holding.
  • Montag & Caldwell first reported a position in Globus Medical in Q1 2024 and has held it in 6 quarters since.
  • Montag & Caldwell's Globus Medical position peaked at $1.33M in Q2 2024.
  • 480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Montag & Caldwell's 13F filing for Q2 2025, filed 15 Aug 2025.